Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. PROTELOS (ranélate de strontium)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

PROTELOS (ranélate de strontium)

Medicine - Posted on Jan 22 2015 - Updated on Jun 12 2019
Active substance (DCI)
  • ranélate de strontium
history (4)
  • 7/9/14

    PROTELOS (strontium ranelate), anti-osteoporosis agent

    The Committee does not recommend reimbursement due to the insufficient clinical benefit in severe osteoporosis. PROTELOS now...
    icône flèche
  • 9/21/11

    PROTELOS

    -
    CAV :
    54321
    icône flèche
  • 7/5/06

    PROTELOS (ranélate de strontium)

    PROTELOS (ranélate de strontium)
    icône flèche
  • 3/2/05

    PROTELOS 2g, granulés pour suspension buvable (Boîte de 28 et Boîte de 56 sachets)

    PROTELOS 2g, granulés pour suspension buvable (Boîte de 28 et Boîte de 56 sachets)
    icône flèche
Technical information
ATC code
  • M05BX03
Manufacturer
SERVIER
Presentation

PROTELOS 2 g, granulés pour suspension buvable (code CIS : 65618140)
28 sachet(s) papier polyéthylène aluminium - Code CIP : 34009 365 170 3 5
56 sachet(s) papier polyéthylène aluminium - Code CIP : 34009 565 830 7 2

All our publications
    Bone and cartilage diseases Drug therapy Menopause, andropause

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
VBHe6ydycRz1fjms